Zimmer biomet holdings inc ZBH.US 總覽分析
ZBH 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面獲得最高評分，股利評分不錯，值得長期累積部位。若想獲得較好的進場時機，可參考技術面趨勢與波段評分
ZBH 近期報酬表現
1.98%
Zimmer biomet holdings inc
-3.92%
同產業平均
-0.77%
S&P500
與 ZBH 同產業的標的表現
- SYK Stryker corporation價值 3 分趨勢 3 分波段 5 分籌碼 3 分股利 4 分查看更多
ZBH 公司資訊
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; biologics, sports medicine, extremities and trauma (S.E.T.) products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and ankle, among others.